News

Article

Pharmaceutical Technology

Pharmaceutical Technology-07-02-2001
Volume25
Issue 7

The Role of USP in the Assessment of Microbiological Quality of Pharmaceuticals

USP ensures the microbiological quality of products by way of the development, proposal, and acceptance of general information chapters.

External Link - article-5413.pdf

Articles in this issue
Musings on the Past 25 Years
Reflections on Changes at FDA
Deliver the Dose
Middle-European Pharmaceutics in a Changing World
The BCS: Where Do We Go From Here?
The Role of USP in the Assessment of Microbiological Quality of Pharmaceuticals

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
Benjamin McLeod and Sebastian Lykke Skafte Andersen go behind the headlines to examine the motivations behind recent M&A activity, tariff responses, and more.
Related Content
Blockchain for transparent supply chain tracking | Image Credit: ©Andrey -stock.adobe.com
September 4th 2025

Keys to Navigating the Complex Drug Supply Chain

Susan Haigney
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
September 4th 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
Question mark background | Image Credit: © Leigh-Prather - © Leigh Prather - stock.adobe.com
September 4th 2025

Effectively Using Contamination Control Strategies

Michelle Heiter Susan J. Schniepp
Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail
September 4th 2025

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
September 4th 2025

EMA and WHO Celebrate 10-Year Collaboration

Susan Haigney
Shanghai.China-Jan. 8th 2022: Fosun Pharma company logo on office building at night. A Chinese pharmaceutical company mostly owned by Fosun International | Image Credit: © Robert - stock.adobe.com
September 4th 2025

Fosun Pharma to Exclusively Develop Accro Bioscience Anti-Inflammatory in China

Patrick Lavery
© 2025 MJH Life Sciences

All rights reserved.